232 related articles for article (PubMed ID: 34702288)
1. Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity.
Zhang P; Yang CL; Du T; Liu YD; Ge MR; Li H; Liu RT; Wang CC; Dou YC; Duan RS
J Neuroinflammation; 2021 Oct; 18(1):244. PubMed ID: 34702288
[TBL] [Abstract][Full Text] [Related]
2. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
[TBL] [Abstract][Full Text] [Related]
3. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
[TBL] [Abstract][Full Text] [Related]
4. Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells.
Wang S; Li H; Zhang M; Yue LT; Wang CC; Zhang P; Liu Y; Duan RS
Neurosci Lett; 2016 Jul; 626():25-34. PubMed ID: 27181511
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.
Wang J; Zheng S; Xin N; Dou C; Fu L; Zhang X; Chen J; Zhang Y; Geng D; Xiao C; Cui G; Shen X; Lu Y; Wang J; Dong R; Qiao Y; Zhang Y
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1287-302. PubMed ID: 24043548
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
[TBL] [Abstract][Full Text] [Related]
9. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Aricha R; Mizrachi K; Fuchs S; Souroujon MC
J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
[TBL] [Abstract][Full Text] [Related]
10. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
Xin N; Fu L; Shao Z; Guo M; Zhang X; Zhang Y; Dou C; Zheng S; Shen X; Yao Y; Wang J; Wang J; Cui G; Liu Y; Geng D; Xiao C; Zhang Z; Dong R
Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
[TBL] [Abstract][Full Text] [Related]
11. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
Wang CC; Zhang M; Li H; Li XL; Yue LT; Zhang P; Liu RT; Chen H; Li YB; Duan RS
Neurosci Lett; 2017 Aug; 656():169-176. PubMed ID: 28743581
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.
Huang H; Ran H; Liu X; Yu L; Qiu L; Lin Z; Ou C; Lu Y; Yang W; Liu W
Int Immunopharmacol; 2021 Apr; 93():107434. PubMed ID: 33556668
[TBL] [Abstract][Full Text] [Related]
14. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
[TBL] [Abstract][Full Text] [Related]
15. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
Xiao BG; Duan RS; Zhu WH; Lu CZ
Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
[TBL] [Abstract][Full Text] [Related]
16. [Rapamycin alleviates the symptoms of experimental autoimmune myasthenia gravis rats by down-regulating Th17 cell/regulatory T cell ratio].
Gao X; Wen Y; Wang Z; Wang G; Guo J; Yu L; Wang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):24-30. PubMed ID: 33441225
[TBL] [Abstract][Full Text] [Related]
17. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
[TBL] [Abstract][Full Text] [Related]
18. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
[TBL] [Abstract][Full Text] [Related]
19. Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response.
Sun J; Chen J; Xie Q; Sun M; Zhang W; Wang H; Liu N; Wang Q; Wang M
J Inflamm (Lond); 2023 Nov; 20(1):37. PubMed ID: 37924056
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.
Adikari SB; Lian H; Link H; Huang YM; Xiao BG
Clin Exp Immunol; 2004 Nov; 138(2):230-6. PubMed ID: 15498031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
